Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI

Technical University of Munich20 enrolled

Overview

This study aims at evaluating the diagnostic efficacy of Gadobutrol versus Gadobenate dimeglumine at similar dose of 0.1mmol/kg for assessment of myocardial infarction by delayed enhancement cardiac Magnetic Resonance Imaging

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Enrollment

Conditions

Subacute/Chronic Myocardial Infarction

Interventions

Gadovist® (Gadobutrol), Multihance® (Gadobenate dimeglumin)OTHER

Other (Diagnostic)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of myocardial infarction * Age ≥ 18 years and ≤ 80 years * Informed consent * Male patients as well as female patients using contraceptives Exclusion Criteria: * Patients with a heart pacemaker, with magnetic material or other magnetic implants. * Renal failure (GFR \<30ml/min) * Patients with known allergy to a Gadolinium-containing contrast agent * Drugs or alcohol addiction, dementia

Locations (1)

Institut für Radiologie - Klinikum Rechts der Isar

Munich, Bavaria, Germany

Outcomes

Primary Outcomes

Efficacy (contrast-to-noise ratio)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.